Home > Insider Trading > Filing (0001562180-23-001539)

Filing Details

Accession Number:: 0001562180-23-001539
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-17 20:46:08
Reporting Period:: 2023-02-15

Accepted Time:: 2023-02-17 20:46:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404123	1Life Healthcare Inc	ONEM	Services-Offices & Clinics Of Doctors Of Medicine (8011)	760707204

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1800511	A Lisa Mango	C/O 1Life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco CA 94111	General Counsel And Secretary	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-02-15	11,525	$0.00	99,910	No	4	M	Direct
Common Stock	Acquisiton	2023-02-15	2,221	$0.00	102,131	No	4	M	Direct
Common Stock	Disposition	2023-02-16	7,596	$15.36	94,535	No	4	S	Direct
Common Stock	Disposition	2023-02-17	6,150	$15.32	88,385	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2023-02-15	11,525	$0.00	11,525	$0.00
Common Stock	Restricted Stock Units	Disposition	2023-02-15	2,221	$0.00	2,221	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
34,573			No	4	M	Direct
4,441			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units ("RSUs") convert into the issuer's common stock on a one-for-one basis.
Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the reporting person.
This transaction was executed in multiple trades at prices ranging from $15.31 to $15.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
This transaction was executed in multiple trades at prices ranging from $15.30 to $15.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The RSUs vest in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.